SG Americas Securities’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170K | Sell |
12,137
-19,835
| -62% | -$278K | ﹤0.01% | 2115 |
|
|
2025
Q1 | $431K | Buy |
31,972
+887
| +3% | +$12K | ﹤0.01% | 1699 |
|
|
2024
Q4 | $596K | Buy |
31,085
+14,644
| +89% | +$281K | ﹤0.01% | 1021 |
|
|
2024
Q3 | $374K | Sell |
16,441
-29,615
| -64% | -$674K | ﹤0.01% | 1733 |
|
|
2024
Q2 | $599K | Buy |
+46,056
| New | +$599K | ﹤0.01% | 1433 |
|
|
2024
Q1 | – | Sell |
-40,588
| Closed | -$884K | – | 3031 |
|
|
2023
Q4 | $884K | Sell |
40,588
-62,079
| -60% | -$1.35M | 0.01% | 975 |
|
|
2023
Q3 | $1.58M | Buy |
102,667
+61,676
| +150% | +$946K | 0.02% | 845 |
|
|
2023
Q2 | $975K | Buy |
40,991
+30,732
| +300% | +$731K | 0.01% | 961 |
|
|
2023
Q1 | $261K | Buy |
10,259
+3,690
| +56% | +$93.9K | ﹤0.01% | 2025 |
|
|
2022
Q4 | $192K | Sell |
6,569
-1,713
| -21% | -$50.1K | ﹤0.01% | 2017 |
|
|
2022
Q3 | $170K | Buy |
+8,282
| New | +$170K | ﹤0.01% | 2177 |
|
|
2019
Q1 | – | Sell |
-6,622
| Closed | -$301K | – | 3013 |
|
|
2018
Q4 | $301K | Buy |
6,622
+445
| +7% | +$20.2K | ﹤0.01% | 1848 |
|
|
2018
Q3 | $517K | Buy |
+6,177
| New | +$517K | ﹤0.01% | 1862 |
|
|
2017
Q4 | – | Sell |
-1,819
| Closed | -$250K | – | 3003 |
|
|
2017
Q3 | $250K | Buy |
+1,819
| New | +$250K | ﹤0.01% | 2088 |
|